{"disease":{"id":"peripheral-blood-stem-cell-transplantation","name":"peripheral blood stem cell transplantation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05436418","title":"The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07362810","title":"G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":224,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT04582604","title":"Ruxolitinib and Decitabine for High Risk Hematological Malignancies","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT05088226","title":"Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT05075681","title":"Ruxolitinib and Chidamide for Acute T Cell Lymphoblast Leukemia/ Lymphoblastic Lymphoma","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT05961410","title":"Eltrombopag for Peripheral Blood Stem Cell Harvest","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":46,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT03993639","title":"KRN125 for Mobilization of Hematopoietic Stem Cells","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT00670423","title":"A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Jennifer E. Schwartz","has_results":false},{"nct_id":"NCT01211990","title":"An Exploratory Study of the Characteristics of and Challenges for International Families Seeking Medical Care in the United States","phase":"","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}